Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
biote Corp.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/11/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 08/11/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 08/11/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/10/2023 |
8-K
| Quarterly results |
| 07/07/2023 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 07/06/2023 |
4
| Conlon Mary Elizabeth (General Counsel) has filed a Form 4 on biote Corp.|
Txns:
| Sold 6,240 shares
@ $6.5021, valued at
$40.6k
|
|
| 07/05/2023 |
4
| Conlon Mary Elizabeth (General Counsel) has filed a Form 4 on biote Corp.|
Txns:
| Exercised 24,231 options to buy
@ $0 |
|
| 07/05/2023 |
4
| Cone Stephen Mark (Director) has filed a Form 4 on biote Corp.|
Txns:
| Exercised 6,058 options to buy
@ $0 |
|
| 07/05/2023 |
4
| Jacoby Dana Lynn (Director) has filed a Form 4 on biote Corp.|
Txns:
| Exercised 6,058 options to buy
@ $0 |
|
| 06/09/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 06/09/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 06/08/2023 |
SC TO-I/A
| Form SC TO-I/A - Tender offer statement by Issuer: [Amend] |
| 06/08/2023 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 06/08/2023 |
8-K
| Entry into a Material Definitive Agreement, Material Modifications to Rights of Security Holders, Submission of Matters to a ...|
Docs:
|
"UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Amendment No. 1 to Warrant Agreement, by and between the Company and Continental Stock Transfer & Trust Company",
"Biote Announces Expiration and Results of Exchange Offer and Consent Solicitation Relating to Warrants IRVING, TX - June 8, 2023 - Biote , a leading solutions provider in preventive healthcare through the delivery of personalized hormone therapy, today announced the expiration and results of its previously announced offer to each holder of its outstanding warrants, each whole warrant exercisable for one share of Class A Common Stock, par value $0.0001 per share , of the Company, at an exercise price of $11.50 per share , the opportunity to receive 0.23 shares of Common Stock in exchange for each Warrant tendered by the holder and exchanged pursuant to the offer , and solicitation of consents from holders of the Warrants to amend the Warrant Agreement, dated as of March 1, 2021 , by and bet..." |
|
| 06/08/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 06/07/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 06/07/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 06/07/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data|
Docs:
|
"Underwriting Agreement, by and among the Company, Roth Capital Partners, LLC, as the underwriter, and the Selling Stockholder named therein",
"Underwriting Agreement, by and among the Company, Roth Capital Partners, LLC, as the underwriter, and the Selling Stockholder named therein" |
|
| 06/07/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 06/02/2023 |
4
| Puncochar Mary Joan (Chief Commercial Officer) has filed a Form 4 on biote Corp.|
Txns:
| Granted 221,500 options to buy
@ $5.39, valued at
$1.2M
|
|
| 06/02/2023 |
3
| Puncochar Mary Joan (Chief Commercial Officer) has filed a Form 3 on biote Corp. |
| 05/23/2023 |
S-4/A
| Form S-4/A - Registration of securities, business combinations: [Amend] |
| 05/19/2023 |
4
| MORRIS DEBRA L (Director) has filed a Form 4 on biote Corp.|
Txns:
| Granted 9,110 options to buy
@ $0
Granted 25,007 options to buy
@ $5.83, valued at
$145.8k
|
|
| 05/19/2023 |
4
| Jacoby Dana Lynn (Director) has filed a Form 4 on biote Corp.|
Txns:
| Granted 11,595 options to buy
@ $0
Granted 46,809 options to buy
@ $5.83, valued at
$272.9k
|
|
| 05/19/2023 |
4
| HEYER STEVEN J (Director) has filed a Form 4 on biote Corp.|
Txns:
| Granted 46,809 options to buy
@ $5.83, valued at
$272.9k
|
|
| 05/19/2023 |
4
| HEYER ANDREW R (Director) has filed a Form 4 on biote Corp.|
Txns:
| Granted 12,009 options to buy
@ $0
Granted 46,809 options to buy
@ $5.83, valued at
$272.9k
|
|
| 05/19/2023 |
4
| Cone Stephen Mark (Director) has filed a Form 4 on biote Corp.|
Txns:
| Granted 9,524 options to buy
@ $0
Granted 46,809 options to buy
@ $5.83, valued at
$272.9k
|
|
| 05/19/2023 |
4
| Beer Marc D (Director) has filed a Form 4 on biote Corp.|
Txns:
| Granted 317,163 options to buy
@ $5.83, valued at
$1.8M
|
|
| 05/19/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 05/16/2023 |
S-4/A
| Form S-4/A - Registration of securities, business combinations: [Amend] |
| 05/16/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 05/16/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 05/12/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
|
|
|